Owner Solvay Pharmaceuticals B.V.

Inventors Van Scharrenburg, Gustaaf J.M.; Long, Stephen K.; Kruse, Cornelis G.; Van Der Heijden, Johannes A. M.; Feenstra, Roelof W.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001263927

PCT Pub. Number WO01/85725

Priority 00201699.6 12.05.00 EP

Filing date 10 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 30 September 2004

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 025/30 Drugs for disorders of the nervous system

A61P 025/00 Drugs for disorders of the nervous system

A61P 025/24 Drugs for disorders of the nervous system

A61P 025/22 Drugs for disorders of the nervous system

A61P 025/16 Drugs for disorders of the nervous system

A61K 031/428 - condensed with carbocyclic rings

A61K 031/4439

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

C07D 277/62 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 263/58 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms